SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-18-028134
Filing Date
2018-04-30
Accepted
2018-04-30 09:00:46
Documents
7
Period of Report
2018-06-21
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a18-2974_1def14a.htm DEF 14A 904274
2 GRAPHIC g29741bci001.gif GRAPHIC 4487
3 GRAPHIC g29741bci002.gif GRAPHIC 1902
4 GRAPHIC g29741bci003.gif GRAPHIC 4487
5 GRAPHIC g29741bci004.gif GRAPHIC 1616
6 GRAPHIC g29741cai001.gif GRAPHIC 153086
7 GRAPHIC g29741cai002.gif GRAPHIC 73219
  Complete submission text file 0001104659-18-028134.txt   1234764
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 18786895
SIC: 2834 Pharmaceutical Preparations